CORENGAGER
Live / Registered — Registered (as of 31 Mar 2026)
What this means for you
Registered since 31 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79418518
- Registration number
- 8190814
- Mark type
- Word mark
- Filed
- 20 Nov 2024
- Published for opposition
- 10 Feb 2026
- Registered
- 31 Mar 2026
- Attorney of record
- Priscilla Lauren Speer
Goods and services
- Class 001 — Chemicals: Protein in raw material form for scientific and medical research; diagnostic reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biological preparations for use in cell cultures, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; diagnostic preparations for research laboratory use; biological preparations, for use in scientific research and development, other than for medical or veterinary purposes; biochemical reagents used for non-medical purposes; cell culture reagents for scientific or research purposes
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for detecting, analyzing, diagnosing and treating tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; anti-cancer preparations; diagnostic preparations for medical or veterinary purposes; medicines for human purposes, namely, medicines for detecting, analyzing, diagnosing and treating tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; surgical implants comprised of living tissues; stem cells for medical purposes; vaccines; enzymes for medical purposes; biological preparations for medical purposes for the treatment of tumors, cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic diseases, immune disorder, TORCH infections and immunoglobulin diseases, infectious diseases, immune disease and fibrosis diseases
- Class 042 — Scientific and technological services: Chemical research; chemical analysis; chemical diagnosis for scientific or medical purposes in the nature of chemical analysis; development and testing of chemical production methods; chemical testing and chemistry consultation services; cosmetic research; bacteriological research; biological research; medical research; medical laboratory services, namely, for research, development, testing, and analysis purposes; clinical trials services for others, including the design, management, monitoring, data management, analysis, reporting, and regulatory compliance of clinical trials
Owner
Prosecution history
- 10 Sept 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 10 Sept 2026 — FINAL DISPOSITION PROCESSED
- 20 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 05 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 05 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 30 Jun 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 31 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 10 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Feb 2026 — PUBLISHED FOR OPPOSITION
- 04 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED